KR101815332B1 - 융합 피롤로카르바졸 유도체의 정제 방법 - Google Patents

융합 피롤로카르바졸 유도체의 정제 방법 Download PDF

Info

Publication number
KR101815332B1
KR101815332B1 KR1020127032917A KR20127032917A KR101815332B1 KR 101815332 B1 KR101815332 B1 KR 101815332B1 KR 1020127032917 A KR1020127032917 A KR 1020127032917A KR 20127032917 A KR20127032917 A KR 20127032917A KR 101815332 B1 KR101815332 B1 KR 101815332B1
Authority
KR
South Korea
Prior art keywords
formula
compound
theta
delete delete
rti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127032917A
Other languages
English (en)
Korean (ko)
Other versions
KR20140095116A (ko
Inventor
숀 피. 올웨인
아르노드 그랜듀리
기 피아첸차
세바스티앙 로제
Original Assignee
세파론, 인코포레이티드
테바 산테
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세파론, 인코포레이티드, 테바 산테 filed Critical 세파론, 인코포레이티드
Publication of KR20140095116A publication Critical patent/KR20140095116A/ko
Application granted granted Critical
Publication of KR101815332B1 publication Critical patent/KR101815332B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020127032917A 2010-05-18 2011-05-17 융합 피롤로카르바졸 유도체의 정제 방법 Active KR101815332B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34583110P 2010-05-18 2010-05-18
US61/345,831 2010-05-18
PCT/US2011/036814 WO2011146488A1 (en) 2010-05-18 2011-05-17 Method for purifying a fused pyrrolocarbazole derivative

Publications (2)

Publication Number Publication Date
KR20140095116A KR20140095116A (ko) 2014-08-01
KR101815332B1 true KR101815332B1 (ko) 2018-01-04

Family

ID=44168420

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127032917A Active KR101815332B1 (ko) 2010-05-18 2011-05-17 융합 피롤로카르바졸 유도체의 정제 방법

Country Status (20)

Country Link
US (1) US8884014B2 (cg-RX-API-DMAC7.html)
EP (1) EP2571885B1 (cg-RX-API-DMAC7.html)
JP (2) JP5828594B2 (cg-RX-API-DMAC7.html)
KR (1) KR101815332B1 (cg-RX-API-DMAC7.html)
CN (1) CN102958934B (cg-RX-API-DMAC7.html)
AU (1) AU2011256264B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012029374B1 (cg-RX-API-DMAC7.html)
CA (1) CA2799517C (cg-RX-API-DMAC7.html)
CL (1) CL2012003208A1 (cg-RX-API-DMAC7.html)
EA (1) EA021869B1 (cg-RX-API-DMAC7.html)
ES (1) ES2530015T3 (cg-RX-API-DMAC7.html)
IL (2) IL223016A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012013304A (cg-RX-API-DMAC7.html)
MY (1) MY156830A (cg-RX-API-DMAC7.html)
NZ (1) NZ604135A (cg-RX-API-DMAC7.html)
PH (1) PH12012502250A1 (cg-RX-API-DMAC7.html)
SG (2) SG10201503541WA (cg-RX-API-DMAC7.html)
UA (1) UA108498C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011146488A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201209305B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965204B (zh) 2008-11-19 2016-09-07 赛福伦公司 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
WO2010059795A1 (en) 2008-11-19 2010-05-27 Cephalon, Inc. Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7109229B2 (en) * 2000-09-29 2006-09-19 Eli Lilly And Company Methods and compounds for treating proliferative diseases
JP2006241579A (ja) 2005-03-07 2006-09-14 Nippon Paint Co Ltd 化成処理剤及び表面処理金属

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
WO2010059795A1 (en) 2008-11-19 2010-05-27 Cephalon, Inc. Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound

Also Published As

Publication number Publication date
IL242221A0 (en) 2015-11-30
BR112012029374A8 (pt) 2017-12-26
SG185645A1 (en) 2012-12-28
AU2011256264A1 (en) 2013-01-10
WO2011146488A1 (en) 2011-11-24
AU2011256264B2 (en) 2016-09-15
KR20140095116A (ko) 2014-08-01
UA108498C2 (en) 2015-05-12
CN102958934B (zh) 2015-06-17
BR112012029374B1 (pt) 2021-05-25
US20130123499A1 (en) 2013-05-16
JP2013526573A (ja) 2013-06-24
CN102958934A (zh) 2013-03-06
BR112012029374A2 (pt) 2016-07-26
JP5828594B2 (ja) 2015-12-09
ES2530015T3 (es) 2015-02-25
CA2799517A1 (en) 2011-11-24
SG10201503541WA (en) 2015-06-29
EA201291269A1 (ru) 2013-05-30
HK1182100A1 (en) 2013-11-22
CA2799517C (en) 2019-01-22
ZA201209305B (en) 2014-02-26
PH12012502250A1 (en) 2013-02-04
IL242221B (en) 2018-06-28
IL223016A0 (en) 2013-02-03
CL2012003208A1 (es) 2013-05-17
NZ604135A (en) 2015-02-27
MY156830A (en) 2016-03-31
EA021869B1 (ru) 2015-09-30
MX2012013304A (es) 2013-04-03
EP2571885B1 (en) 2014-11-12
JP2016074668A (ja) 2016-05-12
US8884014B2 (en) 2014-11-11
EP2571885A1 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
CA2834821A1 (en) Crystalline salts of asenapine
JP2022526675A (ja) 2-(3,5-ジクロロフェニル)-6-ベンズオキサゾールカルボン酸1-デオキシ-1-メチルアミノ-d-グルシトールの製造方法
CN111499640A (zh) 哌嗪并三唑类衍生物的手性拆分方法
WO2011153221A1 (en) Solid state forms of ixabepilone
AU2011256264B2 (en) Method for purifying a fused pyrrolocarbazole derivative
CN108101934B (zh) 用于制备曲贝替定的方法及其中间体
CN1960982B (zh) 分离1,3-二氧杂环己烷-4,6-二酮化合物的方法
HK1182100B (en) Method for purifying a fused pyrrolocarbazole derivative
JP2000355587A (ja) 3−ヒドロキシテトラヒドロフランの製造方法
CN114478536A (zh) 四氢吡嗪稠环衍生物的制备方法
BR112012029363B1 (pt) Processo para preparar 1-alquil-3-difluorometil-5 -hidroxipirazóis
CN114790161B (zh) 4-甲氧基羰基乙基-3-甲基-2-吡咯醛的合成方法及其中间体
JP2717995B2 (ja) 1,2,3−トリアゾールの製法
WO2016142173A1 (en) 4-(2-methyl-1h-imidazol-1-yl)-2,2-diphenylbutanenitrile solid form
EP2462144B1 (en) PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
WO2026088970A1 (ja) ビフェナントレン骨格含有ジヒドロキシ化合物を含有する組成物及びその製造方法
WO2026088971A1 (ja) ビフェナントレン骨格含有ジヒドロキシ化合物の結晶の製造方法
TW202540077A (zh) 具有抗癌活性之mdm2-p53交互作用的異吲哚啉酮抑制劑的中間體的製造方法
US20100179318A1 (en) Process to make lestaurtinib
WO2022034427A1 (en) An improved process for the preparation of 4-oxoisotretinoin
TW202610622A (zh) 2-(3,5-二氯-1-甲基-吲唑-4-基)-1-[(1s,3r)-3-(羥甲基)-5-(1-羥基-1-甲基-乙基)-1-甲基-3,4-二氫-1h-異喹啉-2-基]乙酮一水合物之製造方法
WO2009014679A1 (en) Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereof
CZ20023312A3 (cs) Příprava a izolace @substituovaných@pyridylkarboxylových kyselinŹ jejich karboxylových solí a produktů redukce
WO2014208586A1 (ja) 三環性複素環化合物の製造方法
WO2016113277A1 (en) Method for preparing 4-cyanopiperidine hydrochloride

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121217

Patent event code: PA01051R01D

Comment text: International Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20140625

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160517

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170720

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20170928

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20171228

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20171228

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20201218

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20231214

Start annual number: 7

End annual number: 7